Navigation Links
Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders
Date:10/26/2011

ect with an American company in July.  The company is also developing a kit based on innovative biomarkers, for cancer detection (breast and colon) in blood tests.  A trial based on samples from sick and healthy people from the Oncology department is headed by Prof. Tamar Peretz, and is making progress on a multi-centered trial kit.

BioMarCare laboratories are situated within the Hadassah Oncology department enabling close research and clinical cooperation including access to the hospital's sample archives.

KAHR Medical Ltd.

KAHR received a significant investment and vote of confidence from the pharmaceutical giant – Sanofi (formally known as Sanofi-Aventis). In addition, Sanofi committed to participate in an additional funding round for the company, which is currently being finalized.

KAHR Medical has breakthrough technology in the cancer and inflammatory fields. The treatment targets two complimentary attributes of the disease and provides a synergistic effect. A clinical trial is expected to begin towards the end of 2012 at Hadassah Hospital.

Cell Cure Neurosciences Ltd.

Cell Cure is active in the innovative field of driving and preparing fetal stem cells for the treatment of neurological and eye diseases. The aim of the company's leading product is to treat AMD disease (age-related macular degeneration), which is the main cause of blindness in the aging population. The company is nearing advanced trial stages of the animal model, which will form the basis for contact with regulatory authorities in Israel and abroad, so clinical trials can begin. The company has access to the hospital's cell pool, and to the researchers' expertise. Teva Ltd. and the American company BioTime Inc. are stockholders and partners in the company's progress.

In closing, I would like to thank all of our partners, shareholders, and dedicated employees for their support.  The entire Hadasit
'/>"/>

SOURCE Hadasit Bio-Holdings Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xian Qinba Xintong Medical Ltd.
2. CTI Receives NASDAQ Letter
3. Synvista Therapeutics Posts Letter to Stockholders on Web Site
4. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
5. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
6. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
7. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
8. Cell Therapeutics to Request a Hearing With NASDAQ Following Receipt of Staff Determination Letter
9. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
10. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
11. deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 The next session of ... 2014 and will comprise of the increasingly popular ‘Base ... TechTrainings is a series of technical hands-on classes for ... them reach the next step in their professional careers. ... taught by Jennifer Kang, Senior Statistician at Genentech and ...
(Date:7/21/2014)... 21, 2014 With a larger, ... the new Cole-Parmer® Digital Gear Pump Drive ... to operate for automated process applications. , Simply ... The batch count function counts down and displays ... tracks amount dispensed across multiple cycles. View the ...
(Date:7/21/2014)... yield so far is small, but chemists at the ... substitution process to make a precursor to transparent thin ... energy devices. , A paper describing the approach is ... of the journal Inorganic Chemistry , which draws ... nuclear chemistry fields. The paper was chosen by the ...
(Date:7/21/2014)... 21, 2014 Sleep disturbances such ... closely correlated with depression. According to a study ... "About three quarters of depressed patients have insomnia ... of young depressed adults and 10% of older ... cause huge distress, have a major impact on ...
Breaking Biology Technology:Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3New Easy-View Cole-Parmer Digital Gear Pump Drive Makes Performance Monitoring Effortless 2Oregon chemists eye improved thin films with metal substitution 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 3
... , , ROCKVILLE, Md., July 21 ... appointment of John J. Trizzino as Senior Vice President, International ... Trizzino will report directly to Dr. Rahul Singhvi, Novavax,s President ... managing the company,s international alliances with pharmaceutical companies and all ...
... ... is pleased the U.S. Environmental Protection Agency will allow farmers the ability to improve upon ... for SmartStax, an insect-protection and weed control platform in corn, to 5 percent in the ... ...
... , , NEWARK, N.J., July 21 ... a specialty chemical technology based Life Science Company announced ... protocol testing, BioNeutral,s Ygiene(TM) Hospital Grade Antimicrobial passed the ... all 5.4 million spores of Clostridium difficile ...
Cached Biology Technology:Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances 2EPA Refuge Determination Positive for the Environment 2BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing. 2BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing. 3
(Date:7/22/2014)... of both still images and video of artistic ... Forty-four still images were chosen from more than ... and alumni representing more than 25 different University ... 50 submissions. , Zach Donnell, a graduate student ... organizers, noted that the exhibit highlights the interplay ...
(Date:7/22/2014)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2014. Revenue ... increase of 53% compared to $4.4 million in the same ... the second quarter of 2014 was $1.4 million compared to ... in revenue and operating income was driven by higher sales ...
(Date:7/22/2014)... science and engineering professor with an expertise in big ... Foundation grant worth more than $600,000 to develop an ... Heng Huang, an associate professor, will lead the project ... Computer Science and Engineering department. Scientists are compiling and ... number of genes involved in fruit fly development are ...
Breaking Biology News(10 mins):Art of Science 2014 2Aware, Inc. Reports Second Quarter 2014 Financial Results 2Aware, Inc. Reports Second Quarter 2014 Financial Results 3Aware, Inc. Reports Second Quarter 2014 Financial Results 4Aware, Inc. Reports Second Quarter 2014 Financial Results 5Aware, Inc. Reports Second Quarter 2014 Financial Results 6Aware, Inc. Reports Second Quarter 2014 Financial Results 7UT Arlington big data team wins $600,000 NSF grant to build gene expression database 2
... Researchers speaking in the first plenary session of the ... (IAS 2011) have today offered insights into current and ... developments over the past two years are beginning ... policy. The presentations reflect the breadth of expertise ...
... trailing a long length of rope behind you is not ... to manoeuvre, and can get tangled up or stuck on ... apart during cell division. The chromosomes are pulled by their ... Just like climbers carry their rope coiled up, cells make ...
... PHILADELPHIA The use of trastuzumab, chemotherapy and ... improved survival from the time central nervous system metastases ... researcher Adam Brufsky, M.D., Ph.D., said, "We clearly now ... chemotherapy, even if cancer spreads to the brain." ...
Cached Biology News:Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combination of biomedical and non biomedical approaches to HIV prevention policy 2Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combination of biomedical and non biomedical approaches to HIV prevention policy 3Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combination of biomedical and non biomedical approaches to HIV prevention policy 4Keeping it together 2Trastuzumab and chemotherapy improved survival in HER2-postive breast and brain cancer patients 2
Mouse monoclonal [050-04] to C2 ( Abpromise for all tested applications). entrezGeneID: 717 SwissProtID: P06681...
C/EBPalpha Antibody Shipping Temperature: Cold Storage Temperature: -20C...
...
AADAC Immunogen: AADAC (NP_001077, 201 a.a. ~ 301 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: